Vimarsana
Biggest News Aggregation in the World

Although Claritas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Although Claritas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Although Claritas Today - Breaking & Trending Today

Claritas Announces Approval from OTC to Up-List to OTCQB - Vimarsana News

Claritas Announces Approval from OTC to Up-List to OTCQB

SAN FRANCISCO, CA and TORONTO, ON, April 07, 2022 -- Claritas Pharmaceuticals, Inc. is pleased to announce that it has obtained approval from the OTC Markets Group for listing of its Common... | April 7, 2022

Claritas Announces Agreement with CMAX Clinical Research for Phase 1 Clinical Study of R-107 - Vimarsana News

Claritas Announces Agreement with CMAX Clinical Research for Phase 1 Clinical Study of R-107

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Claritas Announces Agreement with CMAX Clinical Research for Phase 1 Clinical Study of R-107 Claritas Pharmaceuticals, Inc.April 21, 2021 GMT SAN FRANCISCO and TORONTO, April 21, 2021 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the “Company” or “Claritas”) today announced that it has entered into an agreement with CMAX Clinical Research Pty Ltd (“CMAX”) to conduct a randomized, placebo-controlled, single-blind, single ascending dose Phase 1 clin...

Source: apnews.com
Claritas Announces Letter of Intent to Acquire Exclusive Worldwide Rights to Develop R-107 for PAH - Vimarsana News

Claritas Announces Letter of Intent to Acquire Exclusive Worldwide Rights to Develop R-107 for PAH

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Claritas Announces Letter of Intent to Acquire Exclusive Worldwide Rights to Develop R-107 for PAH Claritas Pharmaceuticals, Inc.April 14, 2021 GMT SAN FRANCISCO and TORONTO, April 14, 2021 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the “Company” or “Claritas”) today announced that it has entered into a binding Letter of Intent (the “LOI”) with Salzman Group, Inc. (a Delaware corporation), Salzman Group, Ltd. (an Israeli corporation), and Salzm...

Source: apnews.com
Claritas (Formerly Kalytera Therapeutics) Cites Breakthrough Data by Massachusetts General ... - Vimarsana News

Claritas (Formerly Kalytera Therapeutics) Cites Breakthrough Data by Massachusetts General ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Claritas (Formerly Kalytera Therapeutics) Cites Breakthrough Data by Massachusetts General ... Claritas Pharmaceuticals, Inc.March 2, 2021 GMT SAN FRANCISCO, March 02, 2021 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (formerly Kalytera Therapeutics, Inc.) (TSX VENTURE: KLY and OTC: KALTF) (the “Company” or “Claritas”) today announced that compelling data demonstrating that nitric oxide achieved viral clearance in severe and critical COVID-19 patients validates the potential of the Com...

Source: apnews.com